化合物管理の世界市場2020-2040

◆英語タイトル:GLOBAL COMPOUND MANAGEMENT MARKET FORECAST 2020-2028
◆商品コード:INK20MY029
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年3月
◆ページ数:162
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは化合物管理の世界市場について調査・分析し、調査範囲・手法、エグゼクティブサマリー、市場動向、主要分析、製品・サービス別(器具、ソフトウェア)分析、試料別(化学物質、生体試料)分析、用途別(創薬、遺伝子合成、バイオバンク)分析、エンドユーザー別(製薬企業、バイオ医薬品企業、開発業務受託機関、その他)分析、地域別分析、企業情報などの情報をお届けいたします。
・調査範囲・手法
・エグゼクティブサマリー
・市場動向
・主要分析
・化合物管理世界市場:製品・サービス別(器具、ソフトウェア)
・化合物管理世界市場:試料別(化学物質、生体試料)
・化合物管理世界市場:用途別(創薬、遺伝子合成、バイオバンク)
・化合物管理世界市場:エンドユーザー別(製薬企業、バイオ医薬品企業、開発業務受託機関、その他)
・地域別分析
・企業情報
【レポートの概要】

KEY FINDINGS
The global compound management market is predicted to register a CAGR of 14.12% during the forecast period, 2020-2028. The factors propelling the growth of the market are growing R&D activities in the pharmaceutical and biotech sectors, a beneficial biobanking sector, and a growing number of clinical trials.

MARKET INSIGHTS
Chemical libraries are vital to the drug discovery process. The chemicals are kept in environmentally-regulated conditions, and the management of these libraries entails compound management. The compound management involves the renewal of outdated chemicals, robots used for the movement of chemicals, maintaining a database of chemicals, and quality control of the storage environment. There is a rise in the number of clinical trials. They are essential in the better understanding and determination of suitable medical approaches for a particular therapeutic domain. Also, the growing number of several communicable and non-communicable diseases has resulted in increased demands for new drugs or medical devices.
However, the lack of skilled professionals is what impedes the market growth. The biopharmaceutical and pharmaceutical companies are outsourcing the services to the CRO industry for maintaining the revenue and tackle several challenges apart from minimizing cost and time needed for testing. The lack of highly skilled professionals for testing services in accordance with the national and international regulatory standards hampers the growth of the market. The competitive nature of the environment and the success of the companies are set to be determined by collaborations, innovations, and acquisitions.

REGIONAL INSIGHTS
The geographical segmentation of the global compound management market includes North America, Europe, Asia Pacific, and the rest of the world. The Asia Pacific region is set to be the fastest-growing market region with regard to the compound management market during the forecast period. The increasing expenditure on R&D and government initiatives are the factors attributed to such growth prospects.

COMPETITIVE INSIGHTS
The global compound management market is set to witness an intensified competitive rivalry among the market players. Some of the well-established players in the market are Beckman Coulter Inc, Bioascent, Brooks Life Sciences, Axxam S.P.A., Biosero Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. GROWTH IN R&D ACTIVITIES IN PHARMACEUTICAL AND BIOTECH SECTOR
3.2.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS CONDUCTED
3.2.3. BIO BANKING SECTOR PUSHING THE MARKET GROWTH
3.3. KEY RESTRAINTS
3.3.1. LACK OF SKILLED PROFESSIONALS
3.3.2. COMPOUND MANAGEMENT FACILITIES ARE CAPITAL INTENSIVE
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. GROWTH STRATEGIES
4.5.1. ORGANIC GROWTH STRATEGIES
4.5.2. INORGANIC GROWTH STRATEGIES
5. MARKET BY PRODUCTS & SERVICES
5.1. PRODUCT
5.1.1. INSTRUMENTS
5.1.1.1. AUTOMATED COMPOUND/SAMPLE STORAGE SYSTEMS MARKET
5.1.1.2. MANUAL COMPOUND/SAMPLE STORAGE SYSTEMS MARKET
5.1.1.3. AUTOMATED LIQUID HANDLING SYSTEMS MARKET
5.1.2. SOFTWARE
5.2. SERVICES
6. MARKET BY SAMPLE TYPE
6.1. CHEMICAL COMPOUNDS
6.2. BIOSAMPLES
7. MARKET BY APPLICATION
7.1. DRUG DISCOVERY
7.2. GENE SYNTHESIS
7.3. BIOBANKING
8. MARKET BY END USER
8.1. PHARMACEUTICAL COMPANIES
8.2. BIOPHARMACEUTICAL COMPANIES
8.3. CONTRACT RESEARCH ORGANISATION
8.4. OTHERS
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. UNITED KINGDOM
9.2.2. GERMANY
9.2.3. FRANCE
9.2.4. ITALY
9.2.5. RUSSIA
9.2.6. BELGIUM
9.2.7. POLAND
9.2.8. REST OF EUROPE
9.3. ASIA PACIFIC
9.3.1. CHINA
9.3.2. JAPAN
9.3.3. INDIA
9.3.4. SOUTH KOREA
9.3.5. INDONESIA
9.3.6. THAILAND
9.3.7. VIETNAM
9.3.8. AUSTRALIA & NEW ZEALAND
9.3.9. REST OF ASIA PACIFIC
9.4. REST OF WORLD
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST & AFRICA
10. COMPANY PROFILES
10.1. AXXAM S.P.A.
10.2. BECKMAN COULTER INC
10.3. BIOASCENT
10.4. BIOSERO INC
10.5. BROOKS LIFE SCIENCES
10.6. EVOTEC
10.7. HAMILTON COMPANY
10.8. ICAGEN INC
10.9. LICONIC SYSTEMS
10.10. TCG LIFESCIENCES PVT LTD
10.11. TECAN TRADING AG
10.12. TITIAN SOFTWARE
10.13. SPT LABTECH (NAME CHANGED FROM TTP LABTECH)
10.14. WUXI APPTEC
10.15. HIGHRES BIOSOLUTIONS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[化合物管理の世界市場2020-2040]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆